Number of the records: 1
TRAIL (Apo2L) supresses growth of primary human leukemia and myelodysplasia progenitors
- 1.PLÁŠILOVÁ, M., ŽIVNÁ, J., JELÍNEK, J., NEUWIRTOVÁ, R., ČERMÁK, J., NEČAS, E., ANDĚRA, Ladislav, STOPKA, T. TRAIL (Apo2L) supresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia. 2002, 16(1), 67-73. ISSN 0887-6924. E-ISSN 1476-5551.
Number of the records: 1